Robert Hoffman

Robert Hoffman

Chief Executive Officer chez KINTARA THERAPEUTICS, INC.

Fortune : 101 083 $ au 31/03/2024

58 ans
Health Technology
Technology Services
Miscellaneous

Profil

Mr. Robert E.
Hoffman
, CPA, is an Independent Director at FibroBiologics, Inc., a Chairman at Antibe Therapeutics, Inc., an Independent Non-Executive Director at Aslan Pharmaceuticals Ltd., a Chairman, President, Chief Executive Officer & CFO at Kintara Therapeutics, Inc. and an Independent Director at ASLAN Pharmaceuticals Pte Ltd.
He is on the Board of Directors at FibroBiologics, Inc., Aslan Pharmaceuticals Ltd., Day For Change and ASLAN Pharmaceuticals Pte Ltd.
Mr. Hoffman was previously employed as an Independent Director by Saniona AB, an Independent Director by Aravive, Inc., an Independent Director by Versartis, Inc., a Chief Financial Officer & Senior VP-Finance by Heron Therapeutics, Inc., a Chief Financial & Accounting Officer, Executive VP by Innovus Pharmaceuticals, Inc., a Chief Financial Officer by AnaptysBio, Inc., an Independent Director by Kura Oncology, Inc., an Independent Director by MabVax Therapeutics Holdings, Inc., an Independent Director by CombiMatrix Corp., a Chief Financial Officer by Polaris Group, Inc., a President & Director by Financial Executives International of San Diego Chapter, a Chief Financial Officer & Senior VP-Finance by Arena Pharmaceuticals, Inc., and an Assistant Controller by Document Sciences Corp.
He also served on the board at Zeta Acquisition Corp.
III and Telik, Inc. He received his undergraduate degree from St. Bonaventure University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
24/01/2024 7 500 ( 0,02% ) 81 075 $ 31/03/2024
11/01/2024 38 334 ( 0,07% ) 12 842 $ 31/03/2024
14/09/2023 68 902 ( 0,18% ) 7 166 $ 31/03/2024

Postes actifs de Robert Hoffman

SociétésPosteDébut
KINTARA THERAPEUTICS, INC. Chief Executive Officer 08/11/2021
ASLAN PHARMACEUTICALS LIMITED Director/Board Member 30/10/2018
ANTIBE THERAPEUTICS INC. Chairman 25/05/2022
FIBROBIOLOGICS, INC. Director/Board Member 08/04/2021
Director/Board Member -
Day For Change Director/Board Member -
Tous les postes actifs de Robert Hoffman

Anciens postes connus de Robert Hoffman

SociétésPosteFin
SANA AB Director/Board Member 25/05/2022
KURA ONCOLOGY, INC. Director/Board Member 03/08/2021
HERON THERAPEUTICS, INC. Director of Finance/CFO 16/10/2020
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Robert Hoffman

Formation de Robert Hoffman

St. Bonaventure University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Robert Hoffman

Relations

100 +

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées8
HERON THERAPEUTICS, INC.

Health Technology

ANAPTYSBIO, INC.

Health Technology

KINTARA THERAPEUTICS, INC.

Health Technology

KURA ONCOLOGY, INC.

Health Technology

ANTIBE THERAPEUTICS INC.

Health Technology

SANA AB

Health Technology

ASLAN PHARMACEUTICALS LIMITED

Health Technology

ARAVIVE, INC.

Health Technology

Entreprise privées13

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Miscellaneous

Finance

Health Technology

Health Technology

Financial Executives International of San Diego Chapter

Health Technology

Day For Change

FibroBiologics, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Robert Hoffman